LAS VEGAS--(BUSINESS WIRE)--CardioVascular BioTherapeutics, Inc. (OTCBB:CVBT), today announced that Thomas J. Stegmann, M.D., has been named co-president of the company. As co-founder and chief clinical officer, Dr. Stegmann pioneered the protein-based angiogenesis procedure upon which the company was founded. He will share leadership responsibilities with Daniel C. Montano, co-founder, who currently serves as president and CEO.
